Patents by Inventor Elliot Campbell

Elliot Campbell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SARS-CoV-2 Vaccines and Antibodies
    Publication number: 20230212232
    Abstract: The invention describes a method of generating antibodies to a mixture of SARS-CoV-2 peptidogenic proteins or polynucleotides encoding SARS-CoV-2 peptidogenic proteins wherein the SARS-CoV-2 peptidogenic protein has altered conformational dynamics as compared to a SARS-CoV-2 starting protein and wherein the SARS-CoV-2 peptidogenic protein has a similar conformation to the SARS-CoV-2 starting protein. The SARS-CoV-2 peptidogenic proteins can be used to induce an immune response, which can lead to the generation of antibodies and/or can be used to vaccinate a mammal.
    Type: Application
    Filed: March 2, 2023
    Publication date: July 6, 2023
    Applicant: Rutgers, the State University of New Jersey
    Inventors: Stephen Anderson, Elliot Campbell
  • NOVEL METHODS OF GENERATING ANTIBODIES
    Publication number: 20230042877
    Abstract: The invention describes a method of generating antibodies to a mixture of peptidogenic proteins wherein the peptidogenic protein has altered conformational dynamics as compared to a starting protein and wherein the peptidogenic protein has a similar conformation to the starting protein. The peptidogenic proteins can be used to induce an immune response, which can lead to the generation of antibodies and/or can be used to vaccinate a mammal.
    Type: Application
    Filed: June 8, 2022
    Publication date: February 9, 2023
    Applicant: Rutgers, The State University of New Jersey
    Inventors: Stephen Anderson, Elliot Campbell
  • Methods of generating antibodies
    Patent number: 11384138
    Abstract: The invention describes a method of generating antibodies to a mixture of peptidogenic proteins wherein the peptidogenic protein has altered conformational dynamics as compared to a starting protein and wherein the peptidogenic protein has a similar conformation to the starting protein. The peptidogenic proteins can be used to induce an immune response, which can lead to the generation of antibodies and/or can be used to vaccinate a mammal.
    Type: Grant
    Filed: August 18, 2016
    Date of Patent: July 12, 2022
    Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventors: Stephen Anderson, Elliot Campbell
  • NOVEL METHODS OF GENERATING ANTIBODIES
    Publication number: 20180244759
    Abstract: The invention describes a method of generating antibodies to a mixture of peptidogenic proteins wherein the peptidogenic protein has altered conformational dynamics as compared to a starting protein and wherein the peptidogenic protein has a similar conformation to the starting protein. The peptidogenic proteins can be used to induce an immune response, which can lead to the generation of antibodies and/or can be used to vaccinate a mammal.
    Type: Application
    Filed: August 18, 2016
    Publication date: August 30, 2018
    Applicant: Rutgers, The State University of New Jersey
    Inventors: Stephen Anderson, Elliot Campbell